CD 26 (GAG > AAG) refers to the mutation of glutamate to lysine at position 26 of the β-globin peptide chain, which reduces the amount of β-globin gene synthesis but synthesizes HbE that is still functional with abnormal structure and reduces the degree of anemia in patients [23]. The gene discussed is HBE1; the disease is anemia (phenotype).